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ABSTRAK
Tujuan: untuk mendapatkan karakteristik, variasi jenis massa dan tindakan penunjang diagnostik, serta 
faktor-faktor mortalitas saat perawatan pada pasien dengan massa mediastinum yang telah didiagnosis dan 
tatalaksana di RSCM dalam kurun waktu 10 tahun. Metode: penelitian ini merupakan studi kasus kontrol, dengan 
menelusuri rekam medik 113 pasien dengan massa mediastinum selama bulan Januari 2000-Desember 2009 di 
RSCM, Jakarta. Pada analisis faktor-faktor mortalitas; sepsis, syok, pneumonia, tuberkulosis paru, sindrom vena 
cava superior, efusi pelura masif, efusi perikard dan gagal napas digunakan regresi logistik analisis multivariat. 
Hasil: terdapat 201 pasien dengan massa mediastinum selama kurun waktu sepuluh tahun, dan 113 pasien 
memenuhi kriteria penelitian (69 pria dan 44 wanita dengan usia rerata 47 tahun). Massa mediastinum 
terbanyak terdapat pada kisaran usia 18-60 tahun. Pasien yang memberikan keluhan saat awal diagnosis 
sebanyak 107 kasus. Lokasi massa terbanyak pada kompartemen anterosuperior. Foto toraks dapat mendeteksi 
61 kasus massa mediastinum. Empat puluh dua pasien menjalani tindakan torakotomi untuk mendapatkan 
hasil jenis massa secara histopatologi. Mortalitas saat perawatan di rumah sakit mencapai 39,8%. Regresi 
logistik analisis multivariat mendapatkan faktor sepsis (p=0,000), sindrom vena kava superior (p=0,000), dan 
efusi pleura masif (p=0,047), sebagai faktor bermakna yang berhubungan dengan mortalitas saat perawatan. 
Kesimpulan: gambaran klinis dan radiologis pada studi ini menunjukkan bahwa massa mediastinum dapat 
menyerupai gejala penyakit lain. Jenis dan modalitas diagnostik pada studi ini berbeda dibandingkan studi lainnya 
(baik di dalam maupun luar negeri) yang pernah dilaporkan dengan proporsi mortalitas yang tinggi saat perawatan.
Kata kunci: massa mediastinum, sepsis, sindrom vena kava superior, efusi pleura masif.
ABSTRACT
Aim: to obtain characteristics, variations of the type of mass, diagnostic modalities, and mortality factors during 
hospitalization in patients with mediastinal mass at our institute during a 10-year period. Methods: a case-control 
study was conducted, by browsing through the medical records of 113 mediastinal mass patients who were treated 
at Cipto Mangunkusumo Hospital, Jakarta, during a 10-year period (January 2000-December 2009). Factors 
associated with mortality, i.e; sepsis, septic shock, pneumonia, lung tuberculosis, superior vena cava syndrome, 
massive pleural effusion, pericard effusion, and respiratory failure were analyzed by logistic regresion multivariate 
analysis. Results: two hundred and one mediastinal mass patients were diagnosed and treated at our institute, 
113 medical records were available to be included in this study. There were 69 males and 44 females with the 
age range of 18-60 years. One-hundred and seven patients were symptomatic at presentation. Mediastinal tumor 
was the most common mediastinal mass found among the subjects. The most frequent mass location was in the 
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anteriosuperior compartement. Chest X-ray imaging were able to detect 61 cases of mediastinal mass, while 42 
patients underwent thoracotomy (open biopsy) to acquire histopathology diagnosis. The proportion of mortality 
during hospitalization reached 39.8%. Logistic regression multivariate analysis found sepsis (p=0.000), superior 
vena cava syndrome (p = 0.000), and massive pleural effusion (p=0.047), were significant factors associated with 
mortality during hospitalization. Conclusion: the clinical and radiologic features of mediastinal mass patients in 
our institute showed that mediastinal mass may resemble the symptoms of other diseases. Types and diagnostic 
modalities performed in our study differs from other studies previously reported in other countries with a high 
proportion of mortality during hospitalization.
Key words: mediastinal mass, sepsis, superior vena cava syndrome, massive pleural effusion.
INTRODUCTION
Various diseases may emerge in or involve 
the mediastinum. These diseases may include 
primary tumors, metastatic tumors, cysts or acute 
and chronic infections. Mediastinal mass is a term 
for mass(es) in the mediastinum, i.e. the space 
between right and left lungs. The mediastinal 
space is narrow and cannot be expanded, thus 
a growth in this space will compress adjacent 
organs and cause a life-threatening emergency. 
Most mediastinal masses grow slowly, and 
thus patients often seek medical attention as 
the mass gets large enough, accompanied by 
signs of symptoms due to the compression of 
the mass to adjacent organs. Factors known to 
be associated with increased morbidity rate are 
infection, pulmonary emergency, cardiovascular 
emergency, and neurologic emergency. Infection 
include sepsis, septic shock, pneumonia, and 
pulmonary tuberculosis; pulmonary emergency-
massive pleural effusion and respiratory failure; 
cardiovascular emergency–superior vena cava 
syndrome and massive pericardial effusion, 
while neurologic emergency–myasthenia crisis.1-3 
A prompt and appropriate evaluation on those 
factors is very important in the management of 
patients with mediastinal masses, particularly as 
a guide to determine useful diagnostic modalities, 
treatment options and to facilitate appropriate 
evaluation on various levels of diagnostic 
process and treatment. Increased patient’s risks 
will determine when the treatment should be 
conducted aggressively to provide better result, 
ease the patient’s suffering, and to reduce the 
mortality rate.4
In comparison with reports from abroad, data 
regarding mediastinal mass in Indonesia is still 
scarce. In view of the broad clinical and radiologic 
manifestations of mediastinal mass and how they 
often resemble other diseases, hence study of 
mediastinal mass patients in Indonesia, especially 
at our institute (Cipto Mangkunkusumo hospital, 
which is a major general public hospital and 
the national refferal hospital in Central Jakarta, 
Indonesia) is needed. Results obtained from 
this study will give important epidemiology 
data (10 years) regarding mediastinal mass, 
treatment, outcome of treatment in Indonesia, 
especially at our institute and could guide 
clinicians to establish the diagnosis of patients 
with mediastinal mass and to stratify patients 
with high mortality factors in order to conduct 
more optimal patient management.
METHODS
Sample
We conducted a case control study to 
analyze factors associated with mortality during 
hospitalization. Data were obtained from patients’ 
medical records. Study was conducted between 
April 2010–July 2010 by browsing medical 
records of mediastinal mass patients treated 
in our institute from January 2000–December 
2009. Samples were collected by browsing and 
documenting all outpatient and inpatient medical 
records who had been diagnosed (based on chest 
x-ray and or histopathology) with mediastinal 
masses in Cipto Mangunkusumo Hospital of the 
within the aforementioned period.
Subjects
In the analysis on factors associated with 
mortality during hospitalization, all mediastinal 
mass patients who died during hospitalization 
within January 2000–December 2009 were 
included in the case group. In the other hand, we 
conducted simple random sampling to include the 
control group, i.e.; patients who survived during 
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hospitalization. A ratio of case:control = 1:1 was 
utilized. Study has been aproved by the Ethical 
Committe of University of Indonesia (approval 
number 135/PT02.FK/ETIK2010) and patients' 
confidentiality was maintained throughout the 
study.
Statistical Analysis
Data collected were subsequently processed 
using SPSS version 16.0. Both descriptive and 
analytic data were presented in text, tables, or 
diagrams as necessary. Factors associated with 
mortality (sepsis, septic shock, pneumonia, 
lung tuberculosis, superior vena cava syndrome, 
massive pleural effusion, pericard effusion, and 
respiratory failure) were analyzed by logistic 
regression multivariate analysis.
RESULTS
Two hundred and one mediastinal mass cases 
were recorded in the hospital data registry within 
the 10-year period (January 2000-Desembar 
2009). We successfully collected 113 medical 
records of those patients while the remaining 
88 patients were excluded from our study since 
their medical records were not found. Most of 
the patients were males, with a ratio of 3:2 and 
mostly within the range of 18-60 years, as seen 
in Table 1. Seven (6.2%) of the cases were found 
in pediatric, while 106 (93.8%) in adults patients, 
with a ratio of 15:1. The youngest patient was 6 
years and the oldest was 85 years of age.
anterosuperior compartement, were symptomatic 
at presentation. (Table 2 and 3)
Table 2. Clinical manifestations
Symptoms n (%) Physical findings & complication n (%)
Cough 82 (72.6) Lymphadenopathy 21 (18.6)
Dyspnea 81 (71.7) Rales 51 (45.1)
Chest pain 23 (20.4) Wheezing 2 (1.8)
Wheezing 2 (1.8) SVCS 33 (29.2)
Pleural effusion 28 (24.8)
Myasthenia gravis 21 (18.6)
Non-respiratory symptoms





Night sweat 23 (20.4)
Husky voice 12 (10.6)
Tabel 1. Demographic profile
Variables n (%)
Gender
 - Male 69 (61.1)
 - Female 44 (38.9)
Age
 - <18 years 7 (6.2)
 - 18–60 years 77 (68.1)
 - >60 years 29 (25.7)
Table 3. The presence of clinical symptoms based on 
mass location in thoracic cavity
Location 
Symptomatic Asymptomatic
n (%) n (%)
Anterosuperior 56 (47.1)  4 (66.7)
Anteroinferior 2 (1.7)  0 (0.0)
Media 20 (16.8)  0 (0.0)
Posterosuperior 7 (5.9)  0 (0.0)
No CT scan 34 (28.5)  2 (33.0)
One hundred and seven patients (94.2%) 
were symptomatic, while six patients (5.2%) 
were asymptomatic at presentation. Respiratory 
symtoms were the most common initial symtoms, 
whereas fine crackles in 51 (45.1%) patients 
and SVCS in 33 (29.2%) patients were the most 
common physical examination findings and 
complications. Majority of the mass located in the 
All 113 patients had chest X-ray while 
thoracic CT scans were performed in 77 (68.1%) 
subjects. Thirty six (31.9%) subjects without 
thoracic CT scan were still included in the study 
since their clinical and histopathologic data were 
available in their medical records. Chest X-ray 
could detect 61 (79.2%) mediastinal masses while 
the remaining were either normal in 10 (8.8%) 
subjects or had some forms of abnormalities 
other than mediastinal masses in 14 (12.4%) 
cases. Based on the location found from chest 
X-ray examination, the most common location 
was superior mediastinal found in 27 (23.9%) 
cases followed by right mediastinal in 21 (18.6%) 
cases. Apart from chest X-ray findings, thoracic 
CT scans found that in 60 (48.0%) subjects the 
mass were located at anterosuperior mediastinal 
and in 20 (16.0%) cases in medial mediastinal 
compartment. Various kinds of mediastinal mass 
based on histopathological examination is shown 
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in Table 4. Mediastinal tumor (44.2%) was 
the most common mass found, with thymoma 
(25.0%) as the most common mediastinal 
tumors and 51 (45.1%) mediastinal mass were 
undiagnosed by histopathologic examinations. 
Fifty one subjects in whom histopathological 
diagnosis were not confirmed was due to 
mortality in 27 (52.9%), while the materials were 
not available in another 17 (33.3%), and in the 
remaining 7 (13.8%) subjects, histopathology 
results were inconclusive.
removed and three patients died after surgery.
Among 113 patients with mediastinal mass, 
45 (39.8%) patients died during hospitalization. 
Highest mortality occurred in patients with 
respiratory failure, which occurred in 25 patients 
(100%), septic shock in 11 patients (11%) and the 
lowest mortality was obtained from pulmonary 
tuberculosis in 5 patients (50%). Logistic 
regresion multivariate analysis was conducted 
on the variables with p value of <0.25 to get 
adjusted OR value. Sepsis, superior vena cava 
syndrome (SVCS), and massive pleural effusion 
were statistically significant factors found to be 
associated with mortality during hospitalization. 
(Table 5)
Table 4. Types of mediastinal masses
N %
Tumor 50 44.2
 - Thymoma 27 25.0
 - Lymphoma 3 2.8
 - Seminoma 2 1.8
 - Teratoma 1 0.9
 - Neurogenic Tumor 1 0.9
 - Other Tumors:
 - Thymic carcinoma 7 6.5
 - Carcinoma 9 8.3




Other Mass 3 2.7
Undiagnosed 51 45.1
Forty-two patients (37.2%) underwent 
surgery/open biopsy to obtain the histopathologic 
diagnosis. In the remaining 71 patients, trans 
thoracal biopsy (TTB) (14 cases;12.4%), CT 
guided trans thoracal aspiration (4 cases; 3.5%), 
pleural fluid cytology (4 cases; 3.5%), fine 
needle aspiration cytology (FNAC) of the lymph 
nodes (LN) (4 cases; 3.5%), sputum cytology 
(3 cases; 2.7%), bronchial lavage cytology (2 
cases, 1.8%) while the rest (40 cases; 35.4%) 
did not undergo any diagnostic procedures due 
to poor performance status or severe concomitant 
disease. In patients with surgery/open biopsy 
procedure, diagnosis was acquired in 42 patients 
(67.7%), TTB in 12 (19.4%), and LN FNAC in 
3 patients (4.8%), while sputum cytology and 
bronchial lavage cytology were undiagnostic. 
Thirty-six out of 42 patients who underwent 
surgery successfully had their mediastinal mass 
Table 5. Multivariate analysis of factors associated with 
mortality during hospitalization
Variables Odds Ratio (95% CI) P
Sepsis 36.243 (7.201 – 182.418) 0.000
SVCS 19.649 (4.541 – 85.021) 0.000
Massive pleural 
effusion
7.828 (1.025 – 59.793) 0.047
DISCUSSION 
In the present study, more male subjects 
with mediastinal masses were observed, i.e. 69 
(61.1%) subjects with ratio of 3:2. This result is 
similar to that of Vaziri M et al.5 which found 
62% of 105 cases were male subjects. On the 
other hand, a study conducted by Junior RS et 
al.4 reported 53.5% of 114 cases were female, 
implying no sex predilection for mediastinal 
masses. Moreover, the most common range of age 
group was 18-60 years, which was found in 77 
(68.1%) subjects. Similar result was also found 
by Nelson TG et al.6 who found the most common 
age range of 18-45 years in 75% subjects and the 
study results by Júnior RS et al.4 demonstrating 
age range between 20-49 years in 57 subjects of 
114 patients with mediastinal masses.
In the present study, majority of subjects were 
symptomatic at presentation, i.e. in 107 (94.7%). 
It is similar to observations reported by Nelson 
TG et al.6 (97% of 141 patients) and Dubashi et 
al.8 (97% of 91 patients). Meanwhile, several 
studies also reported comparable findings in a 
fewer proportion ranging from 61–88%. These 
includes study by Blegvad S et al.10 (61% of 129 
patients), Davis et al7 (62% of 400 subjects), 
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Bastos P et al.9 (68% of 171 patients), Júnior RS 
et al.4 (68% of 114 patients), Adegboye VO et al.11 
(77.1% of 105 patients), and Vaziri et al.5 (88% of 
105 patients). Most presenting symptoms during 
the diagnosis were associated with malignant 
lesions.7,4,11
On the other hand, 6 (5.3%) subjects in the 
present study were asymptomatic at presentation. 
The observed proportion of asymptomatic 
patients is much less than reports from Vaziri et 
al.5 (12%), Adegboye VO et al.11 (22.9%), Júnior 
RS et al.4 (30.8%), Bastos P et al.9 (32%), Davis 
et al.7 (38%), and Blegvad S et al.10 (39%). This 
observation may be due to the fact that a large 
proportion of patients in Indonesia visit hospital 
because of their symtoms rather than due to 
routine examination results. This is contrary from 
other countries where most of mediastinal mass 
is found through a routine examination.12
Based on the location within the thoracic 
cavity, 56 (47.1%) subjects with anterosuperior 
mass were symptomatic at presentation. Similar 
findings with higher proportions was reported 
by Davis et al7 (75%) and Adegboye VO et al.11 
(86.6%) with anterosuperior location as the 
most common compartment in subjects who had 
symptoms at the time of diagnosis. The presence 
of mass in the anterosuperior mediastinal is more 
likely to cause symptoms due to compression or 
invasion of the mass to the adjacent airway that 
may lead to airway obstruction.13
Rales was the most common physical 
finding; found in 50 (45.1%) subjects. However, 
no data of rales percentage in patients with 
mediastinal mass was reported from other studies. 
Lymphadenopathy was found in 21 (18.6%) 
subjects with supraclavicular lymphadenopathy 
being the most common findings in 14 (12.4%) 
subjects. A higher proportion of similar results 
was observed in a study conducted by Adegboye 
VO et al.11 which reported lymphadenopathy 
in 33.3% subjects and also in study by 
Dubashi et al.8 that reported 21.9% subjects 
with supraclavicular lymphadenopathy. The 
occurrence of lymphadenopathy is associated 
with malignancy.8
Various complications may accompany a 
mediastinal mass, known as complication because 
it is correlated with compression and/or invasion 
of the mass (mostly tumor) to the adjacent organs 
or resulting from systemic reaction due to tumor.12 
In the present study, SVCS was the most common 
complication in 33 (29.2%) subjects. Such result 
is similar to the study conducted by Dubashi et 
al8 (28% subjects) and by Adegboye VO et al.11 
(23.5% subjects), which are higher compared 
to studies by Bastos P et al.9 (7% subjects) and 
by Vaziri et al.5 (10% subjects). The presence 
of SVCS is associated with malignancy or 
mediastinal tumor.11 Supporting this observation, 
study by Chen JC et al.14 demonstrated that 
pulmonary cancer (75%), mediastinal tumor 
(20%), metastases of solid tumor (5%) was the 
cause of SVCS. In addition, Pratama S12 reported 
that mediastinal tumor was the cause in 27.1% 
patients with SVCS.
Thoracic CT scans in these patients revealed 
the most common location of mediastinal mass 
to be in the anterosuperior compartment as 
found in 60 (48.0%) subjects. Several studies 
also observed that anteriosuperior compartment 
were the most common location but with various 
proportions. The presence of a mediastinal 
mass in the anterosuperior compartment was 
reported by Davis et al.7 (54%), Júnior RS et al.4 
(57.8%), Bastos et al.9 (58%), Adegboye VO et 
al.11 (63.8%), Vaziri et al.5 (65%), Shrivastava 
C.P et al.15 (72%), and Dubashi et al.8 (93.6%). 
Chest X-rays showed that 10 (8.8%) subjects 
had normal imaging and 14 (12.4%) subjects 
had no detectable masses. This may occur since 
CT scan has more advantage compared to chest 
X-ray in detecting mediastinal mass, determining 
the location and characteristics of such masses.
In the present study, chest x-ray detected 61 
(79.2%) cases of mediastinal masses. Such result 
is similar to a study in 90 subjects indicating 
that chest X-ray may only detect 62 (69%) 
cases of mediastinal masses.17 Some literatures 
demonstrate that the accuracy of detection 
depends on mediastinal compartment, i.e. 48% 
(10/21) visualization of medial mediastinal 
mass, 67% (20/30) of anterior compartment, 
and 100% (4/4) of posterior mediastinal mass. 
Although chest X-ray has some limitation and 
there are various superior radiological modalities 
(CT scan, magnetic resonance imaging, positron 
emission tomography scan, etc), but it still has 
important role as initial diagnostic procedure to 
establish the diagnosis for mediastinal mass.17
Mediastinal tumor found in 50 (44.2%) 
subjects was the most common type of mediastinal 
mass in this study. Similarly, at least 10 other 
studies reported that mediastinal tumor as the 
Gurmeet Singh                                                                                                    Acta Med Indones-Indones J Intern Med
8
most common type of mediastinal mass.4–9,11,15,18,19 
Of all mediastinal tumor, thymoma was the 
most common type of mediastinal tumor (in 
27 (25.0%) subjects). The same observations 
are also demonstrated by Davis et al.7 (17% 
subjects), Júnior RS et al.4 (40% subjects), 
Pratama S12 (37.8% subjects), Dubashi et al.8 
(39% subjects), Bastos et al.9 (31% subjects) and 
Shrivastava C.P. et al.15 (31% subjects). Vaziri 
et al.5 observed mediastinal lymphoma as the 
common findings (31.5% subjects) while Nelson 
TG et al.6 reported the same observation in 20.5% 
subjects. Similarly, Adegboye VO et al.11 found 
mediastinal lymphoma in 21.9% subjects. On the 
other hand, Kim KR et al.19 reported germinal cell 
tumor as the most common types of mediastinal 
tumor (28.4% subjects). While dealing with 
patients who had mediastinal mass, mediastinal 
tumor may be considered as the initial diagnosis. 
Open biopsy was the most common procedure 
in this study. Forty two (67.7%) subjects 
underwent open biopsy either as diagnostic 
procedures to determine the type of mediastinal 
tumor histopathologically or as treatment 
modalities, with a low mortality rate (9.8%). 
This finding is similar to the study conducted by 
Lam et al.20 reporting 26 subjects of 29 patients 
who had open biopsy in establishing diagnosis 
of mediastinal mass; however, greater number 
was reported by Dubashi et al.,8 i.e. 28% of 
91 patients. Procedure or modalities to obtain 
the type of mediastinal mass depends on some 
factors; if the mediastinal mass is assumed to 
be benign, capsulated, resectable, and non-
lymphatous lesion based on radiological imaging 
and or difficult to establish diagnosis after 
various examinations, then open biopsy is the 
procedure of choice to obtain definitive etiology 
or treatment.21 In contrast, if the mass seems 
to be invasive and not resectable then biopsy 
could be performed through imaging or surgical 
assistance.22
The incidence of mortality in patients with 
mediastinal mass is associated with some factors, 
namely infection, pulmonary, cardiovascular and 
neurologic emergency.1-3 In the present study, the 
proportion of mortality during hospitalization 
was found in 45 (39.8%) subjects, of whom 16 
(35.6%) subjects were diagnosed with mediastinal 
tumor. In addition, another 27 (52.9%) subjects 
who died with mediastinal masses in whom 
the definite type of mediastinal mass had not 
been identified. This is likely to occur since 
the subjects had come in a very late stage and 
having other concomitant disease as well as 
having financial constraints thus delaying optimal 
diagnostic procedure and appropriate treatment. 
Investigators of the present study did not find 
data of other studies (both local and overseas 
studies) on mortality proportion of subjects with 
mediastinal mass during hospitalization.
In the present study, bivariate and multivariate 
analysis were performed on factors that may be 
associated with mortality during hospitalization. 
By logistic regresion multivariate analysis, 
significant factors include sepsis (OR 36.243; 
95% CI 7.201-182.418; p=0.000), SVCS (OR 
19.649; 95% CI 4.541-85.021; p=0.000) and 
massive pleural effusion (OR 19.649; 95% CI 
4.541-85.021; p=0.047).
Having significantly high OR found from this 
study, sepsis represents a systemic inflammation 
and extensive tissue damage resulting in vascular 
endothelial necrosis which lead to multiple organ 
damage or even death. This was supported by 
Cohen who stated that multiple organ disorder 
is caused by thrombosis and coagulation in 
small blood vessel resulting in septic shock 
and consequently causing death.23 Mortality 
due to sepsis during hospitalization ranges 
between 25%-80%. Risk factors associated 
with bad prognosis include organ dysfunction, 
underlying disease, source of infection and 
microorganisms.24
As a medical emergency, SVCS frequently 
manifests in patients with malignant process of 
the thoracic cavity. Patients with SVCS need an 
immediate diagnostic evaluation and treatment. 
Their survival rate depends on the underlying 
disease. This study showed that 25.6 % of patients 
with mediastinal masses present with SVCS 
and 82.7% of them died during hospitalization. 
A study by Wilson et.al25 showed that around 
10% patients with bronchogenic carcinoma and 
45% patients with lymphoma who had radiation 
may survive for approximately 30 months; 
while patients with SVCS due to malignancy 
who had not had any treatment will die in 30 
days. Superior vena cava syndrome occurs due 
to obstruction of circulation through superior 
vena cava resulting in increased vein pressure. 
The increased vein pressure of the upper part 
of the body will cause edema of the head, neck 
and arms. In severe condition, SVCS may cause 
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laryngeal and brain edema leading to symptoms 
of headache, impaired consciousness and sudden 
death.25
Accumulation of pleural fluid occurs 
when production speed exceeds the reduced 
lymphatic clearance due to malignant infiltration. 
Malignancy is the most common cause of 
massive pleural effusion.26 Jiménezab et al.26 
found that 53.7% etiology of malignancy in 
121 patients with massive pleural effusion. The 
survival rate of patients with massive pleural 
effusion is about 5 months. Park et al.27 reported 
that among 298 subjects with pleural effusion, 
41 (13.8%) subjects had massive pleural effusion 
with malignancy (46.3%) as the most common 
cause, followed by tuberculosis (36.6%), 
parapneumonia effusion (9.8%), and transudate 
(7.3%). This study found high mortality rate in 
patients with massive pleural effusion in whom 
malignant masses were present (66.7%).
This study also found other variables that 
are likely to have association with mortality 
during hospitalization such as pneumonia, 
pulmonary tuberculosis, respiratory failure, 
and myasthenia crisis but failed to demonstrate 
significant correlation in multivariate analysis. 
This may occur due to small sample size to obtain 
statistically significant correlation.
The present study was retrospective in nature 
by analyzing secondary data from medical 
records. Completeness and reliability of data 
largely depends on the records which were 
completed by different physicians. Some history, 
physical findings and other supporting tests 
were not documented in the medical records. In 
addition, despite being conducted in the largest 
tertiary hospital in the country, the results are 
based from a single centre with internal validation 
and therefore, the results should be confirmed and 
validated by a multicentre study to be generalized 
beyond our institution. 
CONCLUSION
The clinical and radiologic features of 
mediastinal mass patients in our institute 
showed that mediastinal mass may resemble 
the symptoms of other diseases. Types and 
diagnostic modalities performed in our study 
differ from other studies previously reported 
with a high proportion of mortality during 
hospitalization. Factors statistically significant 
associated with mortality during hospitalizations 
were sepsis, superior vena cava syndrome, and 
massive pleural effusion. Factors known to be 
associated with mortality should be identified in 
the comprehensive and integrated management 
of patients with mediastinal mass.
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